The effect of ursodeoxycholic acid on the survivin in thapsigargin-induced apoptosis

Cancer Letters

Volumn 191, Issue 1, 2003, Pages 83-92

  Sohn, Joohyun ^a   Khaoustov, Vladimir I ^a   Xie, Qing ^a   Chung, Charles C ^a   Krishnan, Bhuvaneswari ^a   Yoffe, Boris ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Endoplasmic reticulum; Hepatoma cell lines; Survivin; Ursodeoxycholic acid

Indexed keywords

CALPAIN; CASPASE; CASPASE 12; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SURVIVIN; THAPSIGARGIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; STRESS; WESTERN BLOTTING;

EID: 0037470353     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00624-9     Document Type: Article

References (30)

1. Mehmet H. Apoptosis: caspases find a new place to hide. Nature. 403:2000;29-30.
2. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J. Caspase-12 mediates endoplasmic-reticulum apoptosis and cytotoxicity by amyloid-[beta]. Nature. 403:2000;98-103.
3. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150:2000;887-894.
4. Ambrosini G., Adida C., Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:1997;917-921.
5. Deveraux Q.L., Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev. 13:1999;239-252.
6. LaCasse E.C., Baird S., Korneluk R.G., MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17:1998;3247-3259.
7. Jäättelä M. Escaping cell death: survival proteins in cancer. Exp. Cell Res. 248:1999;30-43.
8. Altieri D.C., Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab. Invest. 79:1999;1327-1333.
9. Adida C., Haioun C., Gaulard P., Lepage E., Morel P., Briere J., Dombret H., Reyes F., Diebold J., Gisselbrecht C., Salles G., Altieri D.C., Molina T.J. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 96:2000;1921-1925.
10. Kamihira S., Yamada Y., Hirakata Y., Tomonaga M., Sugahara K., Hayashi T., Dateki N., Harasawa H., Nakayama K. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis. Br. J. Haematol. 114:2001;63-69.
11. Lu C.D., Altieri D.C., Tanigawa N. Expression of novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 58:1998;1808-1812.
12. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58:1998;5071-5074.
13. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinoma. Clin. Cancer Res. 6:2000;127-134.
14. Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., Altieri D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 351:1998;882-883.
15. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:1998;580-584.
16. Tamm I., Wang Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf T., Reed J.C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58:1998;5315-5320.
17. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., Oh B.H. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry. 40:2001;1117-1123.
18. Rodrigues C.M., Ma X., Linehan-Stieers C., Fan G., Kren B.T., Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Diff. 6:1999;842-854.
19. Rodrigues C.M., Fan G., Ma X., Kren B.T., Steer C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101:1998;2790-2799.
20. Xie Q., Khaoustov V.I., Chung C.C., Sohn J., Krishnan B., Lewis D.E., Yoffe B. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 36:2002;592-601.
21. Earnest D.L., Holubec H., Wali R.K., Jolley C.S., Bissonette M., Bhattacharyya A.K., Roy H., Khare S., Brasitus T.A. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res. 54:1994;5071-5074.
22. Batta A.K., Salen G., Holubec H., Brasitus T.A., Alberts D., Earnest D.L. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. Cancer Res. 58:1998;1684-1687.
23. 2+-ATPase. Proc. Natl. Acad. Sci. USA. 87:1990;2466-2470.
24. 2+-ATPase in thapsigargin and Bcl-2 induced changes in Xenopus laevis oocyte maturation. Oncogene. 20:2001;933-941.
25. Baell J.B., Huang D.C. Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochem. Pharmacol. 64:2002;851-863.
26. Hockenbery D. Defining apoptosis. Am. J. Pathol. 146:1995;16-19.
27. Rich T., Watson C.J., Wyllie A. Apoptosis: the germs of death. Nat. Cell Biol. 1:1999;E69-E71.
28. Bitko V., Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase 12) is implicated in the apoptosis of A549 epithelial cell by respiratory syncytial virus. J. Cell. Biochem. 80:2001;441-454.
29. Guicciardi M.E., Gores G.J. Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways. Hepatology. 35:2002;971-973.
30. Qiao L., Yacoub A., Studer E., Gupta S., Pei X.Y., Grant S., Hylemon P.B., Dent P. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology. 35:2002;779-789.